Skip to main content
Skip to content
Info Menu
Show — Info Menu
Hide — Info Menu
Loading data...
Investors
Careers
Global locations
Mega Menu
Show — Mega Menu
Hide — Mega Menu
About Danaher
Approach
News
Science
Search
Mobile Top Menu
Show — Mobile Top Menu
Hide — Mobile Top Menu
Search
Mega Menu
Show — Mega Menu
Hide — Mega Menu
Who we are
About Us
Leadership
Our Businesses
What we stand for
Sustainability
DE+I
Our Process
Danaher Business System
Acquisitions
Partnership Initiatives
Suppliers
Mobile Mega Menu
Show — Mobile Mega Menu
Hide — Mobile Mega Menu
About Danaher
Who we are
About Us
Leadership
Our Businesses
What we stand for
Sustainability
DE+I
Approach
Column 1
Our Process
Danaher Business System
Column 2
Acquisitions
Partnership Initiatives
Suppliers
News
Science
Search
Mega Menu Mobile - Top Level
Show — Mega Menu Mobile - Top Level
Hide — Mega Menu Mobile - Top Level
About Danaher
Approach
News
Science
Search
Info Menu
Show — Info Menu
Hide — Info Menu
Loading data...
Investors
Careers
Global locations
Search
Clear
News
News Topic
Topic
Awards
Company
DE&I
Innovation
Partnerships
Sustainability
Sort by
Changed
Order
Ascending
Descending
The future of pathology is digital
06.18.24
Building a virtual 4D cell
11.12.24
Diagnostics innovation: overlooked for too long
11.06.24
Powering a new paradigm for pathology
11.01.24
DBS in Action: Cepheid’s COVID-19 Response
09.25.24
Diagnosing sepsis: Patients need precision
09.13.24
2023 Danaher Summit Highlight: Valuing Diagnostics
06.13.24
2023 Danaher Summit Highlight: Overcoming Barriers
06.11.24
2023 Danaher Summit Highlights: AI and Data
05.30.24
2023 Danaher Summit Highlights: Patient Access
05.16.24
Brain injury diagnostics: A patient’s perspective
05.10.24
Illuminating the future of genomic medicine
02.29.24
IDT’s Rolf Turk considers the future of CRISPR
02.08.24
Danaher, Innovative Genomics Institute join forces
01.09.24
Leading the Way in the Golden Age of Biology
10.09.23
See more
Press Releases